ArticleCurrent cancer drug targets2024

Withaferin A Inhibits Liver Cancer Tumorigenesis by Suppressing Aerobic Glycolysis through the p53/IDH1/HIF-1α Signaling Axis.

Xiangyang Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.